Working to Eradicate Gynecologic Cancers

Minal Barve, MD

MD
Texas Oncology, P.A.
7777 Forest Lane
Suite C-707
Dallas, TX
USA 75230

Papers:
1 Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: preliminary results